The relationship between astrocyte-mediated metabolism of β-amyloid protein and pathogenesis of the early stages of Alzheimer's disease

Progress in Biochemistry and Biophysics

Volumn 39, Issue 8, 2012, Pages 715-720

  Lin, Lü ^a   Xu, Shu Jun ^a   Wang, Qin Wen ^a  

^a Nintgbo University   (China)

Author keywords

amyloid protein; Alzheimer's disease; Astrocyte; Degradation; Internalization

Indexed keywords

EID: 84870858966     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2012.00134     Document Type: Review

References (52)

1. Zhou J W. Recent progress in neurodegenerative disorder research in China. Sci China Life Sci, 2010, 53( 3): 348-355
2. Cong L, Jia J. Promoter polymorphisms which regulate ADAM9 transcription are protective against sporadic Alzheimer's disease. Neurobiol Aging, 2011, 32( 1): 54-62
3. Tong Z Q, Han C S, Luo W H, et al. Accumulated hippocampal formaldehyde induces age-dependent memory decline. Age, 2012, DOI: 10.1007/s11357-012-9388-8
4. He R Q, Lu J, Miao J Y. Formaldehyde stress. Sci China Life Sci, 2010, 53( 12): 1399-1404
5. Liu Y Y, Qiang M, Wei Y, et al. A novel molecular mechanism for nitrated α-synuclein-induced cell death. J Mol Cell Biol, 2011, 3( 4): 239-249
6. Tong Z Q, Zhang J L, Luo W H, et al. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia. Neurobiology of Aging, 2011, 32( 1): 31-41
7. Xu Y X, Wang H Q, Zhao H, et al. Prog Biochem Biophys, 2011, 38( 10): 908-918
8. Zhang X H, Poo M M. Progress in neural plasticity. Sci China Life Sci, 2010, 53( 3): 322-329
9. Luo Z G. Synapse formation and remodeling. Axon guidance and neuronal migration research in China. Sci China Life Sci, 2010, 53( 3): 315-321
10. Zhang M, Zhao Z M, He L, et al. A meta-analysis of oxidative stress markers in schizophrenia. Sci China Life Sci, 2010, 53( 1): 112-124
11. Sun P, Zhang Q, Han J Y, et al. TLR4 signaling induced TLR2 expression in the process of mimic cerebral ischemia/reperfusion in. vitro. Sci China Life Sci, 2010, 53( 2): 223-228
12. Wang Y Z, Xu T L. Ion channels in neuronal survival. Sci China Life Sci, 2010, 53( 3): 342-347
13. Luo Y F, Zhang J, Liu N Q, et al. Copper ions influence the toxicity of β-amyloid (1-42) in a concentration-dependent manner in a Caenorhabditis elegans model of Alzheimer's disease. Sci China Life Sci, 2011, 54( 6): 527-534
14. Xu S J, Liu G L. Prog Biochem Biophys, 2010, 37( 6): 589-593
15. Liu L L, Sheng B Y, Gong K, et al. Prog Biochem Biophys, 2010, 37( 2): 154-160
16. Paris D, Beaulieu-Abdelahad D, Bachmeier C, et al. Anatabine lowers Alzheimer's abeta production in vitro and in vivo. Eur J Pharmacol, 2011, 670( 2- 3): 384-391
17. Schaeffer E L, Figueiro M, Gattaz W F. Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics (Sao Paulo), 2011, 66( Suppl 1): 45-54
18. Mulder S D, Veerhuis R, Blankenstein M A, et al. The effect of amyloid associated proteins on the expression of genes involved in amyloid-beta clearance by adult human astrocytes. Exp Neurol, 2012, 233( 1): 373-379
19. Garwood C J, Pooler A M, Atherton J, et al. Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis, 2011, 2( 2011): e167
20. Xu M, Zhang H L. Death and survival of neuronal and astrocytic cells in ischemic brain injury: A role of autophagy. Acta Pharmacol Sin, 2011, 32( 9): 1089-1099
21. Maragakis N J, Rothstein J D. Mechanisms of Disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol, 2006, 2 (12): 679-689 (Pubitemid 44782682)
22. Laird F M, Cai H, Savonenko A V, et al. BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci, 2005, 25(50): 11693-11709 (Pubitemid 43098462)
23. Ji B, Maeda J, Sawada M, et al. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies. J Neurosci, 2008, 28 ( 47): 12255-12267
24. Nishitsuji K, Hosono T, Uchimura K, et al. Lipoprotein lipase is a novel amyloid beta (Abeta)-binding protein that promotes glycosaminoglycan-dependent cellular uptake of Abeta in astrocytes. J Biol Chem, 2011, 286( 8): 6393-6401
25. Hampel H. Amyloid-beta and cognition in aging and Alzheimer's disease: Molecular and neurophysiological mechanisms. J Alzheimers Dis, 2012, DOI: 10.3233/JAD-2012-129003
26. Zhao J, O'Connor T, Vassar R. The contribution of activated astrocytes to Abeta production: Implications for Alzheimer's disease pathogenesis. J Neuroinflammation, 2011, 8( 2011): 150
27. Carter S F, Scholl M, Almkvist O, et al. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-ldeprenyl: A multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nucl Med, 2012, 53( 1): 37-46
28. Verkhratsky A, Olabarria M, Noristani H N, et al. Astrocytes in alzheimer's disease. Neurotherapeutics, 2010, 7( 4): 399-412
29. Holler C J, Webb R L, Laux A L, et al. BACE2 expression increases in human neurodegenerative disease. Am J Pathol 2012, 180( 1): 337-350
30. Abdul H M, Sama M A, Furman J L, et al. Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci 2009, 29 ( 41): 12957-12969
31. Parachikova A, Agadjanyan M G, Cribbs D H, et al. Inflammatory changes parallel the early stages of Alzheimer diseas. Neurobiol Aging, 2007, 28(12): 1821-1833 (Pubitemid 47539700)
32. Li C, Zhao R, Gao K, et al. Astrocytes: Implications for neuroinflammatory pathogenesis of Alzheimer's disease. Curr Alzheimer Res, 2011, 8( 1): 67-80
33. Jana A, Pahan K. Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: Implications for Alzheimer's disease. J Neurosci, 2010, 30 ( 38): 12676-12689
34. Hou L, Liu Y, Wang X, et al. The effects of amyloid-beta42 oligomer on the proliferation and activation of astrocytes in vitro. In Vitro Cell Dev Biol Anim, 2011, 47( 8): 573-580
35. Hoozemans J J, Rozemuller A J, van Haastert E S, et al. Neuroinflammation in Alzheimer's disease wanes with age. J Neuroinflammation, 2011, 8( 2011): 171
36. Yin Y I, Bassit B, Zhu L, et al. {gamma}-Secretase substrat e concentration modulates the Abeta42/Abeta40 ratio: implications for Alzheimer disease. J Biol Chem, 2007, 282(32): 23639-23644 (Pubitemid 47311934)
37. Siegenthaler B M, Rajendran L. Retromers in Alzheimer's disease. Neurodegener Dis, 2012, 10( 1- 4): 116-121
38. Tan J, Evin G. Beta-site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis. J Neurochem, 2012, 120 ( 6): 869-880
39. Evin G, Barakat A, Masters C L. BACE: Therapeutic target and potential biomarker for Alzheimer's disease. Int J Biochem Cell Biol, 2010, 42( 12): 1923-1926
40. Mohamed A, Posse de Chaves E. Abeta internalization by neurons and glia. Int J Alzheimers Dis, 2011, 2011: 127984
41. Nielsen H M, Mulder S D, Belien J A, et al. Astrocytic Abeta 1-42 uptake is determined by abeta-aggregation state and the presence of amyloid-associated proteins. Glia, 2010, 58( 10): 1235-1246
42. Chen H K, Ji Z S, Dodson S E, et al. Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease. J Biol Chem, 2011, 286( 7): 5215-5221
43. Basak J M, Verghese P B, Yoon H, et al. Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Abeta uptake and degradation by astrocytes. J Biol Chem, 2012, 287( 17): 13959-13971
44. Jiang Q, Lee C Y, Mandrekar S, et al. ApoE promotes the proteolytic degradation of Abeta. Neuron, 2008, 58(5): 681-693 (Pubitemid 351778466)
45. Tanzi R E, Moir R D, Wagner S L. Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron, 2004, 43(5): 605-608 (Pubitemid 39179722)
46. Larson M E, Lesne S E. Soluble Abeta oligomer production and toxicity. J Neurochem, 2012, 120( Suppl 1): 125-139
47. Lee C Y, Tse W, Smith J D, et al. Apolipoprotein E promotes beta-amyloid trafficking and degradation by modulating microglial cholesterol levels. J Biol Chem, 2012, 287( 3): 2032-2044
48. Schneider L S, Insel P S, Weiner M W. Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's disease neuroimaging initiative. Arch Neurol, 2011, 68( 1): 58-66
49. Golde T E, Schneider L S, Koo E H. Anti-abeta therapeutics in c Alzheimer's disease: The need for a paradigm shift. Neuron, 2011, 69( 2): 203-213
50. Cramer P E, Cirrito J R, Wesson D W, et al. ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science, 2012, 335( 6075): 1503-1506
51. Ahmed R R, Holler C J, Webb R L, et al. BACE1 and BACE2 enzymatic activities in Alzheimer's disease. J Neurochem, 2010, 112( 4): 1045-1053
52. Bahr B A, Wisniewski M L, Butler D. Positive lysosomal modulation as a unique strategy to treat age-related protein accumulation diseases. Rejuvenation Res, 2012, 15( 2): 189-197